Senior Design Teams
SNAMMS Biomedical is looking at addressing misdiagnoses of periodontitis, a tooth and gum disease that results in damaged gum lines and potential for tooth loss. We are developing a device that will alert a dentist or dental hygenist that is probing teeth, letting them know when the right amount of force has been achieved, thus allowing them to better diagnose this disease without having to guess the right amount of force. This device will be beneficial for dental school students to gain a better feel for how to probe teeth, as well as for patients who may experience pain when getting probed by a dental professional.
New Generation Medical
Currently, insulin injection requires a two-handed process, which poses a challenge for patients who have mobility issues or upper limb differences. Considering the overlap of people with diabetes and upper limb differences, this problem is conservatively estimated to affect around 200,000 people in the US. NG Medical has develop an assistive device that addresses the difficulties of using an insulin pen in patients with upper-limb differences. Our goal is to reduce the time and risks associated with injecting insulin one-handed, and bring more independence to those who experience these difficulties.
Neotec is currently in the process of developing a novel method for safely removing electrodes from patients with fragile skin that minimizes the occurrence of skin tear that is easily operable, biocompatible, repeatable, and easily integrated into the current workflow of care. The device will dissolve the adhesive to allow painless removal of the electrode without skin damage or irritation to the patient. This solution will greatly decrease the rate of injury resulting from electrode withdrawal in neonatal and fragile-skin patients.
LANY Medical Devices
LANY Medical Devices is developing a postural support device specifically designed for laparoscopic surgeons to use during operations. This device is comfortable, cooling, easily sterilizable, and aims to relieve back and shoulder strain. As laparoscopic surgeons often suffer from musculoskeletal injuries due to awkward, static positions during their procedures, LANY Medical Devices aims to provide these surgeons relief in order to increase their productivity in the hospital.
HemaHeals is developing a central line assistive-device to aid in the insertion process of central venous catheters. We are working to reduce the mechanical complications, especially the risk of air embolisms, which commonly occur during this complex procedure. The novel solution will be easily integrated into the current workflow, improving the ergonomics for experienced physicians and reducing training time for new physicians.
Cold-blooded is developing a medical cooler with both active and passive cooling components to extend the shelf life of whole blood for Army Ranger combat medics while they are deployed on mission. Whole blood is a life saving resource on the battlefield for soldiers experiencing blood loss from a traumatic injury, so increasing the viability and shelf life of whole blood for the Army Rangers in a combat-scenario could produce life saving results. Our aim is to significantly extend the shelf-life of whole blood on the battlefield through keeping blood refrigerated for longer through a novel blood cooler design.
Existing pulse oximeters overestimate blood oxygen levels (SpO2) in patients of color, especially as the true blood oxygen levels (SaO2) decline, due to darker skin pigmentation in patients of color. As a result, both the absolute value, and the trend in blood oxygen levels, tend to appear less severe in patients of color, potentially resulting in improper treatment for those with darker pigmentation. Our novel solution will modify current pulse oximetry calculations - which utilize the relative absorbance of red and infrared light to estimate SpO2 - to account skin pigmentation.
EmergenTech is developing a controllable, flexible-tip intubation stylet that enables the user to quickly navigate difficult airways during endotracheal intubations. This device will lead to greater first-attempt success rates and shorter intubation times for patients with complicated airways.
Delayed graft function occurs in one-third of kidney transplants as a result of ischemia-reperfusion injury. IRI is a condition that occurs once the organ is implanted and reoxygenated following a period of hypoxia during transport. At Nephronics, we are developing a transport device for donor kidneys to prevent IRI-induced delayed graft function and extend kidney viability. This device will be easily integrated into the organ transport workflow and significantly improve outcomes for kidney transplant patients.
JAMGEN Medical seeks to create an on site, early detection device for Central Line Associated Bloodstream Infections (CLABSI) which are costly, harmful, and prevalent cases that are often not caught until a point of progression that has drained physician/hospital resources, time and severely affected patient well being. This novel solution will allow for early detection of CLABSI so it can be properly caught and treated.
TriCare Innovations is developing an electro optic sensor for irreversible electroporation in tissue, ensuring clinicians can quantify the electric field to optimize treatment for pancreatic cancer. This will allow clinicians to more accurately provide treatment as the electric field at the localized tissue will be able to be directly measured. This is novel as currently temperature measurements are used as an analog for electric field quantification, but this device would allow direct measurement in real time.
PWAB is developing an articulating arthroscopic suture passer that allows the placement of the suture passer mechanism to be more precisely manipulated, as the surgeon will have a larger range of motion for this suture passer when compared to standard practices. This novel solution will lead to easier placement of sutures through soft tissue in arthroscopic and limited access procedures.
Meibomian Gland Dysfunction (MGD) is a disease that causes blockages of the Meibomian glands in eyelids. These blockages prevent the secretion of meibum into the tear film, causing dry eye irritation. There is a need for an at home solution to treat MGD for the estimated 30 million Americans that are affected. While existing clinical solutions are effective, they are expensive and do not provide daily care. The few at home solutions existing on the market are limited in that they only supplement clinical treatment. Lipiflow (Johnson & Johnson) and Nulids (Nusight Medical) are major competitors in the $106.6 million dollar MGD market and $254.7 million dry eye market. We propose an at home solution that uses LEDs to heat and clear blockages.
Current methods of syringe aspiration while locating the target vein during central venous line (CVL) placement require the clinician to maintain negative pressure with one hand, leading to muscle fatigue, instability, and consequently increasing the risk of procedure failure. As a result, medical residents display a 78% failure rate in the CVL placement attempts. This project aims to create a device to increase stability during single-handed cannulation of the target vein in a CVL placement procedure. This will be done by creating a novel, ergonomic device for clinicians to use to ease the difficulty in aspiration.
Sana is developing an expandable pediatric aortic valve for pediatric aortic valve replacement surgery, which aims to reduce the number of pediatric open heart surgeries needed to replace the aortic valve. This unique solution will expand to adapt to pediatric growth so that the implant lifespan is longer than a traditional replacement, therefore reducing the number of needed surgeries.
Cell-ebrate Solutions is developing an improved cervical positioning and manipulation device for gynecological procedures to ensure a reduction of tissue puncture and patient discomfort or pain. This device ensures comfort for the patient while providing ease of use to the provider, leading to greater patient satisfaction and retention during necessary procedures for vaginal and reproductive health.
5 Guys is developing a wearable infant monitoring device that reports heart rate, blood oxygen levels, body temperature, orientation, respiratory rate, and lung sounds. This device is designed to aid in the detection of life threatening events and in the research of sudden unidentified infant deaths.
Biowulf is developing a laparoscopic surgical tissue dissection instrument in order to address clinician pain and discomfort during laparoscopic surgeries and help prevent surgical errors and fatigue due to discomfort in the hand. This novel solution will help lead to less strain on the hand of the clinician actuating the laparoscopic instrument, thereby reducing pain for longer surgeries and ensuring clinician comfort.
Coffee Beans is developing a robotic assistant that can be used by hospital staff to remotely interact with infectious patients and perform small tasks within the patient's room such as pushing buttons and turning knobs. Using this robotic assistant will reduce personal protective equipment (PPE) waste and ultimately reduce the risk of hospital staff contracting infectious diseases.
The GI Joes are developing a endoscope accessory device which aims to assess inflammation in the esophagus via an expanding-cage measuring device. GI clinicians have noted that the current method for assessing inflamation lacks precision and is preformed at an increased cost to the patient. This novel solution will lead to a reduced assessment time, precise measuremnts, and lower end costs to the patient.
WolfOptics is creating an optical sensor to detect the accumulation of blood clots while using an extracorporeal membrane oxygenator (ECMO) machine. This is a single-use disposable device that will serve as an accessory to ECMO machines. It will be beneficial for patients who rely on ECMO machines, such as COVID-19 patients. It will also reduce the need for an ECMO specialist to constantly monitor blood clots with a flashlight. The sensor will allow efficient, accurate, and easier detection of blood clots, and will utilize an audible alarm to alert clinicians to the presence of blood clots.
Over 500,000 patients receive endometrial ablations each year in the US to reduce heavy menstrual bleeding. Current ablation methods inherently damage endometrial tissue, leading to uterus perforation, blood pockets, and complications that result in hysterectomies over 25% of the time. MiKADA Medical is designing a system that utilizes intense pulsed light (IPL) therapy to reduce endometrial vasculature while providing minimal damage to surrounding tissues.